Elanco Animal Health (ELAN)
(Delayed Data from NYSE)
$14.22 USD
+0.09 (0.64%)
Updated Jul 5, 2024 04:00 PM ET
After-Market: $14.44 +0.22 (1.55%) 7:58 PM ET
3-Hold of 5 3
B Value F Growth C Momentum D VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
ELAN 14.22 +0.09(0.64%)
Will ELAN be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for ELAN based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ELAN
Humana's (HUM) CenterWell Sets Foot in Asheville With New Centers
Elanco Animal Health (ELAN) Upgraded to Buy: Here's Why
ELAN: What are Zacks experts saying now?
Zacks Private Portfolio Services
Elanco Animal Health (ELAN) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
U.S. Physical Therapy (USPH) Misses Q1 Earnings Estimates
Countdown to Elanco Animal Health (ELAN) Q1 Earnings: Wall Street Forecasts for Key Metrics
Other News for ELAN
ELAN Alert: Monsey Law Firm of Wohl & Fruchter LLP Investigating Elanco Animal Health Incorporated for Potential Securities Law Violations
Elanco price target lowered to $21 from $23 at Barclays
Barclays Sticks to Its Buy Rating for Elanco Animal Health (ELAN)
Maintaining Buy Rating on Elanco Amid Minor Setbacks: Analyst Sees Long-term Growth Potential
Elanco falls -22.0%